Liquidia Corp.

Is Liquidia Corp. overvalued or undervalued?

As of May 13, 2021, Liquidia Corp. is considered a risky investment due to its high Price to Book Value of 31.19, negative EV to EBIT and EV to EBITDA ratios, and a concerning Return on Equity of -271.66%, despite having previously shown strong long-term returns compared to the S&P 500.

As of 13 May 2021, the valuation grade for Liquidia Corp. has moved from does not qualify to risky, indicating increased concerns regarding its financial health. The company appears to be overvalued given its high Price to Book Value of 31.19 and negative EV to EBIT and EV to EBITDA ratios of -11.61 and -11.80, respectively. Additionally, its Return on Equity (ROE) is alarmingly low at -271.66%, further suggesting that the company is struggling to generate returns for shareholders.<BR><BR>In comparison to its peers, Liquidia Corp.'s P/E ratio of -16.20 is less favorable than Harrow, Inc. at -147.53 and Zymeworks, Inc. at -15.61, both of which also exhibit risky valuations. Notably, while Liquidia has shown impressive returns over longer periods, such as 311.85% over three years compared to the S&P 500's 70.41%, its recent performance has been disappointing, with a 1-week return of -8.63 versus the S&P 500's 1.05%. This divergence highlights the potential risks associated with the stock's current valuation.

Is Liquidia Corp. technically bullish or bearish?

As of August 5, 2025, Liquidia Corp. shows a bullish technical trend with strong MACD and moving averages, despite mixed signals from Dow Theory and OBV, and has significantly outperformed the S&P 500 year-to-date.

As of 5 August 2025, the technical trend for Liquidia Corp. has changed from mildly bullish to bullish. The MACD is bullish on both weekly and monthly timeframes, and moving averages indicate a bullish stance on the daily timeframe. However, the Dow Theory shows a mixed signal with a mildly bearish weekly outlook and a mildly bullish monthly outlook. The Bollinger Bands are mildly bullish on both weekly and monthly timeframes, while the KST is bullish on both timeframes. The OBV presents a mildly bearish weekly signal but is bullish monthly.<BR><BR>Liquidia Corp. has demonstrated strong performance compared to the S&P 500, with a year-to-date return of 109.78% versus the S&P 500's 12.22%, and a one-year return of 148.94% compared to 17.14%. Overall, the current technical stance is bullish, supported by strong MACD and moving average indicators, despite some mixed signals from Dow Theory and OBV.

How big is Liquidia Corp.?

As of Jun 18, Liquidia Corp. has a market capitalization of 1,161.73 million, with net sales of 14.15 million and a net profit of -127.84 million over the latest four quarters. Shareholder's funds are at 77.28 million, and total assets amount to 233.17 million.

As of Jun 18, Liquidia Corp. has a market capitalization of 1,161.73 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of Net Sales for the latest four quarters is 14.15 million, while the sum of Net Profit for the same period is -127.84 million.<BR><BR>As of Dec 24, the reporting period shows Shareholder's Funds at 77.28 million and Total Assets at 233.17 million.

What does Liquidia Corp. do?

Liquidia Corp. is a late-stage clinical biopharmaceutical company focused on developing innovative products, with a market cap of approximately USD 1.16 billion. As of March 2025, it reported net sales of USD 3 million and a net loss of USD 38 million.

Overview:<BR>Liquidia Corp. is a late-stage clinical biopharmaceutical company focused on the development and commercialization of innovative products in the Pharmaceuticals & Biotechnology industry, with a market cap of USD 1,161.73 million.<BR><BR>Financial Snapshot:<BR>- Most recent Net Sales: 3 Million (Quarterly Results - Mar 2025)<BR>- Most recent Net Profit: -38 Million (Quarterly Results - Mar 2025)<BR>- Market cap: USD 1,161.73 Million (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: NA (Loss Making)<BR>- Industry P/E: NA<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: -1.33<BR>- Return on Equity: -271.66%<BR>- Price to Book: 23.37<BR><BR>Contact Details:<BR>- Address: P.O. Box 110085, RESEARCH TRIANGLE PARK NC: 27709<BR>- Tel: 1 919 3284400<BR>- Fax: 1 302 6365454

Should I buy, sell or hold Liquidia Corp.?